Corporate Profile

Anpac Bio is a biotechnology company focusing on early cancer screening and detection and marketing a suite of cancer detection tests, including CDA (cancer differentiation analysis), bio-chemistry, immunology, and genomics tests. Anpac has developed a multi-cancer screening and detection test that uses innovative, patented CDA technology and proprietary cancer-detection device.

Press Releases

Stock Quote


AnPac Bio Fiscal Year 2020 Financial Results

Apr 30, 2021 at 8:30 AM EDT

AnPac Bio First Six Months 2020 Financial Results

Sep 10, 2020 at 8:00 AM EDT

©2021 Anpac Bio-Medical Science Co., Ltd.